S&P 500   5,042.85 (-0.37%)
DOW   37,763.90 (+0.08%)
QQQ   431.10 (+0.01%)
AAPL   171.36 (-0.77%)
MSFT   416.09 (+0.59%)
META   499.90 (-0.07%)
GOOGL   154.19 (-0.43%)
AMZN   184.39 (+0.42%)
TSLA   155.78 (-3.53%)
NVDA   872.60 (+1.46%)
AMD   163.01 (+1.68%)
NIO   3.77 (-3.08%)
BABA   69.80 (-1.16%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.81 (+0.72%)
CGC   6.75 (-3.30%)
DIS   113.34 (+0.35%)
AMC   2.56 (+3.64%)
PFE   25.97 (+0.23%)
PYPL   63.46 (-0.08%)
XOM   118.11 (-1.31%)
S&P 500   5,042.85 (-0.37%)
DOW   37,763.90 (+0.08%)
QQQ   431.10 (+0.01%)
AAPL   171.36 (-0.77%)
MSFT   416.09 (+0.59%)
META   499.90 (-0.07%)
GOOGL   154.19 (-0.43%)
AMZN   184.39 (+0.42%)
TSLA   155.78 (-3.53%)
NVDA   872.60 (+1.46%)
AMD   163.01 (+1.68%)
NIO   3.77 (-3.08%)
BABA   69.80 (-1.16%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.81 (+0.72%)
CGC   6.75 (-3.30%)
DIS   113.34 (+0.35%)
AMC   2.56 (+3.64%)
PFE   25.97 (+0.23%)
PYPL   63.46 (-0.08%)
XOM   118.11 (-1.31%)
S&P 500   5,042.85 (-0.37%)
DOW   37,763.90 (+0.08%)
QQQ   431.10 (+0.01%)
AAPL   171.36 (-0.77%)
MSFT   416.09 (+0.59%)
META   499.90 (-0.07%)
GOOGL   154.19 (-0.43%)
AMZN   184.39 (+0.42%)
TSLA   155.78 (-3.53%)
NVDA   872.60 (+1.46%)
AMD   163.01 (+1.68%)
NIO   3.77 (-3.08%)
BABA   69.80 (-1.16%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.81 (+0.72%)
CGC   6.75 (-3.30%)
DIS   113.34 (+0.35%)
AMC   2.56 (+3.64%)
PFE   25.97 (+0.23%)
PYPL   63.46 (-0.08%)
XOM   118.11 (-1.31%)
S&P 500   5,042.85 (-0.37%)
DOW   37,763.90 (+0.08%)
QQQ   431.10 (+0.01%)
AAPL   171.36 (-0.77%)
MSFT   416.09 (+0.59%)
META   499.90 (-0.07%)
GOOGL   154.19 (-0.43%)
AMZN   184.39 (+0.42%)
TSLA   155.78 (-3.53%)
NVDA   872.60 (+1.46%)
AMD   163.01 (+1.68%)
NIO   3.77 (-3.08%)
BABA   69.80 (-1.16%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.81 (+0.72%)
CGC   6.75 (-3.30%)
DIS   113.34 (+0.35%)
AMC   2.56 (+3.64%)
PFE   25.97 (+0.23%)
PYPL   63.46 (-0.08%)
XOM   118.11 (-1.31%)

What is a COVID-19 vaccine passport, and will I need one?

Virus Outbreak-Viral Questions-Vaccine Passports
What is a vaccine passport, and will I need one? (AP Illustration/Peter Hamlin)

What is a COVID-19 vaccine passport, and will I need one?

“Vaccine passports," or vaccine certificates, are documents that show you were vaccinated against COVID-19 or recently tested negative for the virus. They could help you get into places such as stadiums or even countries that are looking to reopen safely.

The certificates are still being developed, and how and whether they’ll be used could vary widely around the world. Experts say they should be free and available on paper, not just on apps, since not everyone has a smartphone.

In the U.S., federal officials say there are no plans to make them broadly mandatory. In some states, Republican governors have issued orders barring businesses or state agencies from asking people to show proof of vaccination.

Objections revolve mostly around privacy and security — how people’s personal information will be stored — and fairness. Critics say the passports will benefit people and countries with more access to vaccines.

Supporters say they could make reopenings faster and easier. Proof of vaccination or a negative test could be a way for businesses and schools to reassure customers, students and parents that steps are being taken to limit transmission of the virus.

International travel bans by countries could also be eased if people are able to show proof they’re vaccinated. Some countries have long had requirements to prove vaccination against yellow fever.

Still, a challenge is creating certification systems that work across vaccine providers and businesses. More than a dozen initiatives are underway to develop a credential that could be stored on a smartphone or printed on paper, using a QR code.

___

The AP is answering your questions about the coronavirus in this series. Submit them at: FactCheck@AP.org. Read more here:


I got the Johnson & Johnson COVID-19 vaccine. Now what?

Are some COVID-19 vaccines more effective than others?

I got the COVID-19 vaccine. What can I safely do?

Where should you invest $1,000 right now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: